Use of an adenosine A3 receptor agonist for inhibition of viral replication

Details for Australian Patent Application No. 2002219497 (hide)

Owner Can-fite Biopharma Ltd.

Inventors Fishman, Pnina; Khalili, Kamel

Agent Griffith Hack

Pub. Number AU-B-2002219497

PCT Pub. Number WO2002/055085

Priority 60/261,659 16.01.01 US

Filing date 13 January 2002

Wipo publication date 24 July 2002

Acceptance publication date 26 August 2004

International Classifications

A61K 031/52

A61P 031/18 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-B-2002219497

26 August 2004 Application Accepted

  Published as AU-B-2002219497

23 December 2004 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002219498-CHIMERIC T HELPER-B CELL PEPTIDE VACCINE FOR JAPANESE ENCEPHALITIS VIRUS

2002219496-Cellular cushioning material and a method for its production